# Micro-tissue analysis for identifying cellular and molecular signatures from spatial profiling data

Reproducible R code, raw demonstration data, and pre-rendered figures for the
four worked examples in the STAR Protocols article *Micro-tissue analysis for
identifying cellular and molecular signatures from spatial profiling data*.

## Authors

Huiqian Hu,<sup>1,3,\*</sup> Alphonsus H. C. Ng,<sup>1,2,3,\*</sup> and
Yue Lu<sup>1,4,\*\*</sup>

<sup>1</sup>Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT 84112, USA
<sup>2</sup>Department of Biomedical Engineering, University of Utah, Salt Lake City, UT 84112, USA
<sup>3</sup>Technical contact
<sup>4</sup>Lead contact

\* Correspondence: alphonsus.ng@pharm.utah.edu; huiqian.hu@utah.edu
\*\* Correspondence: yue.lu@pharm.utah.edu

- **Lead contact** — Yue Lu (`yue.lu@pharm.utah.edu`).
  Further information and requests for resources should be directed to and
  will be fulfilled by the lead contact.
- **Technical contacts** — Huiqian Hu (`huiqian.hu@utah.edu`) and
  Alphonsus H. C. Ng (`alphonsus.ng@pharm.utah.edu`). Technical questions
  on executing this protocol should be directed to either technical contact.

## Summary

Spatial tissue profiling measures hundreds to thousands of genes or proteins
across regions of a tissue section, but most analyses examine each feature one
at a time. This protocol provides a step-by-step workflow for *micro-tissue
analysis*, which treats each profiled region as its own window into the local
tissue biology. By grouping regions by microenvironment and analysing all
features together, the workflow identifies which genes, proteins, or cell
types collectively drive a biological outcome. All code and worked examples
are provided using two published GeoMx Digital Spatial Profiler datasets from
tumour and mucosal tissues.

For complete details on the use and execution of this protocol, please refer
to Lu et al.<sup>1</sup> and Ng et al.<sup>2</sup>

## What this repository contains

```
.
├── R/
│   ├── Figure 1.R   — PLS-R of CD8A in immune-rich GBM ROIs
│   ├── Figure 2.R   — PLS-DA prediction model for treatment response (5 panels A–E)
│   ├── Figure 3.R   — PLS-R of Ki67 in immune-poor ROIs (highlights B7-H3 / IDO-1)
│   └── Figure 4.R   — Lung-vs-gut PLS-R of Macrophage M1 fraction
├── Nat commun data/        # demonstration dataset 1 (Lu et al., 2021)
│   ├── Raw data.xlsx
│   ├── Raw data_plsda round 1.xlsx
│   └── Raw data_plsda round 2.xlsx
├── Cell Rep data/          # demonstration dataset 2 (Ng et al., 2023)
│   ├── absolute cell fraction.csv
│   └── whole cell fraction.xlsx
└── figures/                # pre-rendered, editable PDFs of the four figures
    ├── Figure 1.pdf
    ├── Figure 2.pdf
    ├── Figure 3.pdf
    └── Figure 4.pdf
```

## How to reproduce the figures

1. Install **R ≥ 4.0** from CRAN (https://cran.r-project.org) and, optionally,
   **RStudio Desktop** from Posit (https://posit.co/download/rstudio-desktop).
2. Clone this repository:

   ```bash
   git clone https://github.com/huiqian-hu/Digipharma-Micro-tissue-analysis.git
   ```

   then open `Digipharma-Micro-tissue-analysis.Rproj` in RStudio. (If you do
   not use RStudio, `setwd()` to the cloned repository's root before sourcing
   any script.)
3. Install the required R packages once:

   ```r
   install.packages(c(
     "here", "readxl", "readr", "tidyr", "dplyr",
     "pls", "ggplot2", "ggrepel", "patchwork",
     "pROC", "viridis"
   ))
   ```

4. Run any of the scripts:

   ```r
   source("R/Figure 1.R")
   source("R/Figure 2.R")
   source("R/Figure 3.R")
   source("R/Figure 4.R")
   ```

   Each script reads its inputs from `Nat commun data/` or `Cell Rep data/`
   and writes its panels into `figures/` as a vector PDF.

## Notes on the analysis

- **Multivariate model.** All four worked examples use partial least squares
  (PLS).<sup>7</sup> Examples 1, 3, and 4 use PLS regression (PLS-R, continuous
  outcome); example 2 uses PLS discriminant analysis (PLS-DA, categorical
  outcome).
- **VIP scores** are computed via the inline helper `pls_vip()`, which
  implements the standard formula
  `VIP_j = sqrt(p · Σ_a (SSY_a · w_aj² / Σ_k w_ak²) / Σ_a SSY_a)`.
  The same helper definition appears in all four scripts so the protocol
  applies one consistent VIP method throughout. With this convention
  `mean(VIP²) = 1`, so the conventional cutoff is `VIP > 1`.
- **Mann–Whitney p-values** (Figure 2D, Figure 3A) use R's exact small-sample
  test (default behaviour of `wilcox.test()`).
- **ROC curves** (Figure 2C, 2E) are drawn with `geom_step(direction = "vh")`
  on data sorted by descending specificity, with an explicit `geom_segment`
  diagonal — see the `roc_panel()` helper at the top of `R/Figure 2.R`.

## Demonstration datasets

| Folder | Source | Tissue | Profiling |
|---|---|---|---|
| `Nat commun data/` | Lu et al., 2021<sup>1</sup> | GBM tumours treated with neoadjuvant anti-PD-1 (168 ROIs across 14 tumours) | GeoMx DSP, 40-protein immuno-oncology panel |
| `Cell Rep data/`   | Ng et al., 2023<sup>2</sup> | Lung and gut autopsy tissue from a COVID-19 case (53 ROIs) | GeoMx DSP, 1,833-transcript Cancer Transcriptome Atlas |

Both demonstration datasets were generated on the NanoString (Bruker) GeoMx
Digital Spatial Profiler.<sup>3</sup> The cell-fraction inputs in
`Cell Rep data/` were derived from the spatial transcript data using
CIBERSORTx.<sup>6</sup>

Please cite the original publications when reusing these data.

## References

1. Lu, Y., Ng, A. H. C., Chow, F. E., Everson, R. G., Helmink, B. A.,
   Tetzlaff, M. T., Thakur, R., Wargo, J. A., Cloughesy, T. F., Prins, R. M.,
   and Heath, J. R. (2021). Resolution of tissue signatures of therapy
   response in patients with recurrent GBM treated with neoadjuvant anti-PD1.
   *Nature Communications* **12**, 4031.
   https://doi.org/10.1038/s41467-021-24293-4
2. Ng, A. H. C., Hu, H., Wang, K., Scherler, K., Warren, S. E.,
   Zollinger, D. R., McKay-Fleisch, J., Sorg, K., Beechem, J. M.,
   Ragaglia, E., et al. (2023). Organ-specific immunity: A tissue analysis
   framework for investigating local immune responses to SARS-CoV-2.
   *Cell Reports* **42**, 113212.
   https://doi.org/10.1016/j.celrep.2023.113212
3. Merritt, C. R., Ong, G. T., Church, S. E., Barker, K., Danaher, P.,
   Geiss, G., Hoang, M., Jung, J., Liang, Y., McKay-Fleisch, J., et al.
   (2020). Multiplex digital spatial profiling of proteins and RNA in fixed
   tissue. *Nature Biotechnology* **38**, 586–599.
   https://doi.org/10.1038/s41587-020-0472-9
4. Kim, L., Ramasamy, K., and Sharma, A. (2026). Protocol for spatial
   profiling of immune cells in the mouse cornea and conjunctiva using
   NanoString GeoMx DSP and nCounterPro platforms. *STAR Protocols* **7**,
   104458. https://doi.org/10.1016/j.xpro.2026.104458
5. Amaria, R. N., Reddy, S. M., Tawbi, H. A., Davies, M. A., Ross, M. I.,
   Glitza, I. C., Cormier, J. N., Lewis, C., Hwu, W. J., Hanna, E., et al.
   (2018). Neoadjuvant immune checkpoint blockade in high-risk resectable
   melanoma. *Nature Medicine* **24**, 1649–1654.
   https://doi.org/10.1038/s41591-018-0197-1
6. Newman, A. M., Steen, C. B., Liu, C. L., Gentles, A. J.,
   Chaudhuri, A. A., Scherer, F., Khodadoust, M. S., Esfahani, M. S.,
   Luca, B. A., Steiner, D., et al. (2019). Determining cell type abundance
   and expression from bulk tissues with digital cytometry.
   *Nature Biotechnology* **37**, 773–782.
   https://doi.org/10.1038/s41587-019-0114-2
7. Wold, S., Sjöström, M., and Eriksson, L. (2001). PLS-regression: a basic
   tool of chemometrics. *Chemometrics and Intelligent Laboratory Systems*
   **58**, 109–130.
   https://doi.org/10.1016/S0169-7439(01)00155-1
